The 2026 American dyslipidemia guideline now endorses the PREVENT equations to guide lipid-lowering therapy in primary prevention in adults. Lipid-lowering therapy can be considered with a 10-year ...
Zacks Investment Research on MSN
RLMD stock surges 42% in a week: Here's what you should know
Shares of Relmada Therapeutics RLMD rallied 42% in a week after the company announced positive 12-month interim data from its ongoing mid-stage study evaluating NDV-01 in patients with high-risk ...
Kettering Health is now facing more than 200 lawsuits related to the fallout from the health system's 2025 cyberattack, in which a ransomware incident caused more than two weeks of care ...
For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...
With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at ...
Millions of Americans between 50 and 65 are rationing medication while waiting for Medicare eligibility — and the shame, ...
SINGAPORE: A 30-year-old man was charged in court on Thursday (Jan 22) with trafficking nearly 2,000 etomidate e-vaporiser pods. The seizure of the pods two days earlier was the biggest by the Health ...
Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on drug discovery and research available to the broader healthcare industry, ...
In a major change to federal marijuana policy, President Donald Trump signed an executive order in December to classify marijuana as a less dangerous substance. On Dec. 18, the president ordered the ...
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.
For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.
WASHINGTON – President Donald Trump signed an executive order Dec. 18 to federally classify marijuana as a less dangerous substance, the biggest change for the drug since 1970 and an opportunity for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results